Should You Buy Alaunos Therapeutics Inc (TCRT) Stock on Friday?
Jan 8 09:10 ET
Alaunos Therapeutics Analyst Ratings
BenzingaAug 16, 2023 08:54 ET
H.C. Wainwright Downgrades Alaunos Therapeutics (TCRT) to a Hold
TipRanksAug 16, 2023 08:45 ET
Alaunos Therapeutics Analyst Ratings
BenzingaAug 15, 2023 10:42 ET
Alaunos Therapeutics Upgraded to Buy at Wainwright on Multiple Catalysts
Seeking AlphaMay 15, 2023 14:13 ET
HC Wainwright & Co. Upgrades Alaunos Therapeutics to Buy, Announces $1.5 Price Target
BenzingaMay 15, 2023 07:21 ET
Alaunos Therapeutics (TCRT) Was Upgraded to a Buy Rating at H.C. Wainwright
TipRanksMay 15, 2023 06:15 ET
Wells Fargo Assumes Alaunos Therapeutics at Overweight, Announces Price Target of $3
BenzingaMar 27, 2023 09:54 ET
Wells Fargo Keeps Their Buy Rating on Alaunos Therapeutics (TCRT)
TipRanksMar 8, 2023 08:56 ET
Analysts Offer Insights on Healthcare Companies: Durect (DRRX), Alaunos Therapeutics (TCRT) and Marinus (MRNS)
TipRanksMar 8, 2023 08:41 ET
H.C. Wainwright Sticks to Their Hold Rating for Alaunos Therapeutics (TCRT)
TipRanksNov 15, 2022 06:46 ET
Alaunos Therapeutics Analyst Ratings
Benzinga Analyst RatingsOct 4, 2022 07:48 ET
Wells Fargo Assumes Alaunos Therapeutics at Overweight, Announces Price Target of $3
Benzinga Real-time NewsOct 4, 2022 07:48 ET
H.C. Wainwright Remains a Hold on Alaunos Therapeutics (TCRT)
TipRanksSep 7, 2022 06:31 ET
Cantor Fitzgerald Assumes Alaunos Therapeutics at Overweight with $3 Price Target
MT NewswiresJul 15, 2022 22:36 ET
Alaunos Therapeutics Price Target Announced at $3.00/Share by Cantor Fitzgerald
Dow JonesJul 15, 2022 08:49 ET
Alaunos Therapeutics analyst ratings
Benzinga Analyst RatingsJul 15, 2022 08:41 ET
Cantor Fitzgerald Assumes Alaunos Therapeutics at Overweight, Announces Price Target of $3
Benzinga Real-time NewsJul 15, 2022 08:40 ET
No Data
No Data